{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T10:54:14Z","timestamp":1793962454588,"version":"4.8.0"},"reference-count":178,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","gastrojournal.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1053\/j.gastro.2017.07.046","type":"journal-article","created":{"date-parts":[[2017,8,3]],"date-time":"2017-08-03T10:00:17Z","timestamp":1501754417000},"page":"390-405","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":517,"title":["The Epidemiology of Esophageal Adenocarcinoma"],"prefix":"10.1053","volume":"154","author":[{"given":"Helen G.","family":"Coleman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-Hua","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5143-5448","authenticated-orcid":false,"given":"Jesper","family":"Lagergren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.gastro.2017.07.046_bib1","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1136\/gutjnl-2012-302412","article-title":"A\u00a0global assessment of the oesophageal adenocarcinoma epidemic","volume":"62","author":"Edgren","year":"2013","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2017.07.046_bib2","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3322\/caac.21185","article-title":"Recent developments in esophageal adenocarcinoma","volume":"63","author":"Lagergren","year":"2013","journal-title":"CA Cancer J Clin"},{"key":"10.1053\/j.gastro.2017.07.046_bib3","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.cgh.2015.10.005","article-title":"The male predominance in esophageal adenocarcinoma","volume":"14","author":"Xie","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2017.07.046_bib4","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1158\/1940-6207.CAPR-16-0170","article-title":"Opportunities for preventing esophageal adenocarcinoma","volume":"9","author":"Maret-Ouda","year":"2016","journal-title":"Cancer Prev Res (Phila)"},{"key":"10.1053\/j.gastro.2017.07.046_bib5","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.canep.2012.07.009","article-title":"Oesophageal cancer survival in Europe: a EUROCARE-4 study","volume":"36","author":"Gavin","year":"2012","journal-title":"Cancer Epidemiol"},{"key":"10.1053\/j.gastro.2017.07.046_bib6","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1111\/jgh.13289","article-title":"Trends in esophageal cancer survival in United States adults from 1973 to 2009: a SEER database analysis","volume":"31","author":"Njei","year":"2016","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2017.07.046_bib7","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1097\/CEJ.0000000000000308","article-title":"Trends in net survival from esophageal cancer in six European Latin countries: results from the SUDCAN population-based study","volume":"26","author":"Launoy","year":"2017","journal-title":"Eur J Cancer Prev"},{"key":"10.1053\/j.gastro.2017.07.046_bib8","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1136\/gutjnl-2014-308124","article-title":"Global incidence of oesophageal cancer by histological subtype in 2012","volume":"64","author":"Arnold","year":"2015","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2017.07.046_bib9","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.canep.2016.01.013","article-title":"The epidemic of oesophageal carcinoma: where are we now?","volume":"41","author":"Thrift","year":"2016","journal-title":"Cancer Epidemiol"},{"key":"10.1053\/j.gastro.2017.07.046_bib10","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1093\/annonc\/mds181","article-title":"The incidence of esophageal adenocarcinoma continues to rise: analysis of period and birth cohort effects on recent trends","volume":"23","author":"Thrift","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1053\/j.gastro.2017.07.046_bib11","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/annonc\/mdt486","article-title":"Patterns and trends in esophageal cancer mortality and incidence in Europe (1980-2011) and predictions to 2015","volume":"25","author":"Castro","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1053\/j.gastro.2017.07.046_bib12","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.canep.2012.09.002","article-title":"Esophageal cancer incidence rates by histological type and overall: Puerto Rico versus the United States Surveillance, Epidemiology, and End Results population, 1992-2005","volume":"37","author":"Gonz\u00e1lez","year":"2013","journal-title":"Cancer Epidemiol"},{"key":"10.1053\/j.gastro.2017.07.046_bib13","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/sj.bjc.6605246","article-title":"Oesophageal cancer incidence in the United States by race, sex, and histologic type, 1977-2005","volume":"101","author":"Cook","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1053\/j.gastro.2017.07.046_bib14","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/ijc.25701","article-title":"No further increase in the incidence of esophageal adenocarcinoma in Sweden","volume":"129","author":"Lagergren","year":"2011","journal-title":"Int J Cancer"},{"key":"10.1053\/j.gastro.2017.07.046_bib15","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1158\/1055-9965.EPI-10-0012","article-title":"Esophageal adenocarcinoma incidence: are we reaching the peak?","volume":"19","author":"Pohl","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1053\/j.gastro.2017.07.046_bib16","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.canep.2017.02.004","article-title":"Incidence trends in oesophageal cancer by histological type: an updated analysis in Sweden","volume":"47","author":"Xie","year":"2017","journal-title":"Cancer Epidemiol"},{"key":"10.1053\/j.gastro.2017.07.046_bib17","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1158\/1055-9965.EPI-13-1233","article-title":"Exploring the recent trend in esophageal adenocarcinoma incidence and mortality using comparative simulation modeling","volume":"23","author":"Kong","year":"2014","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1053\/j.gastro.2017.07.046_bib18","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1158\/1055-9965.EPI-07-0421","article-title":"Decreasing trend of esophageal adenocarcinoma in Hong Kong","volume":"16","author":"Yuk","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1053\/j.gastro.2017.07.046_bib19","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1111\/j.1572-0241.2006.00570.x","article-title":"Opposing trends in incidence of esophageal squamous cell carcinoma and adenocarcinoma in a multi-ethnic Asian country","volume":"101","author":"Fernandes","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2017.07.046_bib20","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.canep.2016.08.002","article-title":"Time trends in the incidence of oesophageal cancer in Asia: variations across populations and histological types","volume":"44","author":"Xie","year":"2016","journal-title":"Cancer Epidemiol"},{"key":"10.1053\/j.gastro.2017.07.046_bib21","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.ejca.2010.01.029","article-title":"Sex differences in the incidence of gastrointestinal adenocarcinoma in Sweden 1970-2006","volume":"46","author":"Ruteg\u00e5rd","year":"2010","journal-title":"Eur J Cancer"},{"key":"10.1053\/j.gastro.2017.07.046_bib22","doi-asserted-by":"crossref","first-page":"38876","DOI":"10.18632\/oncotarget.9113","article-title":"A\u00a0global assessment of the male predominance in esophageal adenocarcinoma","volume":"7","author":"Xie","year":"2016","journal-title":"Oncotarget"},{"key":"10.1053\/j.gastro.2017.07.046_bib23","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1053\/j.gastro.2017.09.046","article-title":"Insights into the pathophysiology of esophageal adenocarcinoma","volume":"154","author":"Quante","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2017.07.046_bib24","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1016\/j.cgh.2014.01.028","article-title":"Familial clustering of Barrett\u2019s esophagus and esophageal adenocarcinoma in a European cohort","volume":"12","author":"Verbeek","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2017.07.046_bib25","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1158\/1055-9965.EPI-06-0293","article-title":"Familiality in Barrett\u2019s esophagus, adenocarcinoma of the esophagus, and adenocarcinoma of the gastroesophageal junction","volume":"15","author":"Chak","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1053\/j.gastro.2017.07.046_bib26","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1007\/s10620-016-4109-2","article-title":"The genetics of Barrett\u2019s esophagus: a familial and population-based perspective","volume":"61","author":"To","year":"2016","journal-title":"Dig Dis Sci"},{"key":"10.1053\/j.gastro.2017.07.046_bib27","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1158\/1055-9965.EPI-11-0927","article-title":"Variation in age at cancer diagnosis in familial versus nonfamilial Barrett\u2019s esophagus","volume":"21","author":"Chak","year":"2012","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1053\/j.gastro.2017.07.046_bib28","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.clinre.2011.07.015","article-title":"History of cancer in first degree relatives of Barrett\u2019s esophagus patients: a case-control study","volume":"35","author":"De Ceglie","year":"2011","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1053\/j.gastro.2017.07.046_bib29","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1001\/jamaoncol.2016.2054","article-title":"Association between germline mutation in VSIG10L and familial Barrett neoplasia","volume":"2","author":"Fecteau","year":"2016","journal-title":"JAMA Oncol"},{"key":"10.1053\/j.gastro.2017.07.046_bib30","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1158\/1055-9965.EPI-15-0832","article-title":"Predicting Barrett\u2019s esophagus in families: an Esophagus Translational Research Network (BETRNet) model fitting clinical data to a familial paradigm","volume":"25","author":"Sun","year":"2016","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1053\/j.gastro.2017.07.046_bib31","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s10620-015-3884-5","article-title":"Genetic biomarkers of Barrett\u2019s esophagus susceptibility and progression to dysplasia and cancer: a systematic review and meta-analysis","volume":"61","author":"Findlay","year":"2016","journal-title":"Dig Dis Sci"},{"key":"10.1053\/j.gastro.2017.07.046_bib32","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1136\/gutjnl-2016-311622","article-title":"Germline variation in\u00a0inflammation-related pathways and risk of Barrett\u2019s oesophagus and oesophageal adenocarcinoma","volume":"66","author":"Buas","year":"2017","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2017.07.046_bib33","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1002\/ijc.29863","article-title":"Polymorphisms in genes in the androgen pathway and risk of Barrett\u2019s esophagus and esophageal adenocarcinoma","volume":"138","author":"Ek","year":"2016","journal-title":"Int J Cancer"},{"key":"10.1053\/j.gastro.2017.07.046_bib34","doi-asserted-by":"crossref","DOI":"10.1002\/ijc.27541","article-title":"Single nucleotide polymorphisms in the matrix metalloproteinase gene family and the frequency and duration of gastroesophageal reflux disease influence the risk of esophageal adenocarcinoma","volume":"131","author":"Cheung","year":"2012","journal-title":"Int J Cancer"},{"key":"10.1053\/j.gastro.2017.07.046_bib35","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1593\/neo.101722","article-title":"Association between polymorphisms in cancer-related genes and early onset of esophageal adenocarcinoma","volume":"13","author":"Wu","year":"2011","journal-title":"Neoplasia"},{"key":"10.1053\/j.gastro.2017.07.046_bib36","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1093\/carcin\/bgu207","article-title":"Integrative post-genome-wide association analysis of CDKN2A and TP53 SNPs and risk of esophageal adenocarcinoma","volume":"35","author":"Buas","year":"2014","journal-title":"Carcinogenesis"},{"key":"10.1053\/j.gastro.2017.07.046_bib37","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/ng.2408","article-title":"Common variants at the MHC locus and at chromosome 16q24.1 predispose to Barrett\u2019s esophagus","volume":"44","author":"Su","year":"2012","journal-title":"Nat Genet"},{"key":"10.1053\/j.gastro.2017.07.046_bib38","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1038\/ng.2796","article-title":"A\u00a0genome-wide association study identifies new susceptibility loci for esophageal adenocarcinoma and Barrett\u2019s esophagus","volume":"45","author":"Levine","year":"2013","journal-title":"Nat Genet"},{"key":"10.1053\/j.gastro.2017.07.046_bib39","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1053\/j.gastro.2014.10.041","article-title":"Polymorphisms near TBX5 and GDF7 are associated with increased risk for Barrett\u2019s esophagus","volume":"148","author":"Palles","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2017.07.046_bib40","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1002\/cam4.641","article-title":"The Barrett-associated variants at GDF7 and TBX5 also increase esophageal adenocarcinoma risk","volume":"5","author":"Becker","year":"2016","journal-title":"Cancer Med"},{"key":"10.1053\/j.gastro.2017.07.046_bib41","first-page":"5","article-title":"Single nucleotide polymorphisms in CRTC1 and BARX1 are associated with esophageal adenocarcinoma","volume":"14","author":"van Nistelrooij","year":"2015","journal-title":"J\u00a0Carcinog"},{"key":"10.1053\/j.gastro.2017.07.046_bib42","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/S1470-2045(16)30240-6","article-title":"Genome-wide association studies in oesophageal adenocarcinoma and Barrett\u2019s oesophagus: a large-scale meta-analysis","volume":"17","author":"Gharahkhani","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1053\/j.gastro.2017.07.046_bib43","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1016\/j.cgh.2014.01.039","article-title":"Risk of esophageal adenocarcinoma decreases with height, based on consortium analysis and confirmed by Mendelian randomization","volume":"12","author":"Thrift","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2017.07.046_bib44","first-page":"106","article-title":"Obesity and risk of esophageal adenocarcinoma and Barrett\u2019s esophagus: a Mendelian randomization study","volume":"30","author":"Thrift","year":"2014","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1053\/j.gastro.2017.07.046_bib45","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1093\/jnci\/djt303","article-title":"Germline genetic contributions to risk for esophageal adenocarcinoma, Barrett\u2019s esophagus, and gastroesophageal reflux","volume":"105","author":"Ek","year":"2013","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1053\/j.gastro.2017.07.046_bib46","first-page":"557","article-title":"Diagnosis of cystic fibrosis in the Republic of Ireland: epidemiology and costs","volume":"100","author":"Farrell","year":"2007","journal-title":"Ir Med J"},{"key":"10.1053\/j.gastro.2017.07.046_bib47","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1177\/2050640615611018","article-title":"Genetic susceptibility to Barrett\u2019s oesophagus: Lessons from early studies","volume":"4","author":"Findlay","year":"2016","journal-title":"United Eur Gastroenterol J"},{"key":"10.1053\/j.gastro.2017.07.046_bib48","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1158\/1055-9965.EPI-15-0507","article-title":"A\u00a0newly identified susceptibility locus near FOXP1 modifies the association of gastroesophageal reflux with Barrett\u2019s esophagus","volume":"24","author":"Dai","year":"2015","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1053\/j.gastro.2017.07.046_bib49","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1001\/jama.1995.03530060048032","article-title":"The relation of gastroesophageal reflux disease and its treatment to adenocarcinomas of the esophagus and gastric cardia","volume":"274","author":"Chow","year":"1995","journal-title":"JAMA"},{"key":"10.1053\/j.gastro.2017.07.046_bib50","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1056\/NEJM199903183401101","article-title":"Symptomatic gastoroesophageal reflux as a risk factor for esophageal adenocarcinoma","volume":"340","author":"Lagergren","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1053\/j.gastro.2017.07.046_bib51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0103508","article-title":"Gastroesophageal reflux in relation to adenocarcinomas of the esophagus: a pooled analysis from the Barrett\u2019s and Esophageal Adenocarcinoma Consortium (BEACON)","volume":"9","author":"Cook","year":"2014","journal-title":"PLoS One"},{"key":"10.1053\/j.gastro.2017.07.046_bib52","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1136\/gut.2007.131375","article-title":"Combined effects of obesity, acid reflux and smoking on the risk of adenocarcinomas of the oesophagus","volume":"57","author":"Whiteman","year":"2008","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2017.07.046_bib53","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1002\/cncr.11568","article-title":"Hiatal hernia, reflux symptoms, body size, and risk of esophageal and gastric adenocarcinoma","volume":"98","author":"Wu","year":"2003","journal-title":"Cancer"},{"key":"10.1053\/j.gastro.2017.07.046_bib54","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1023\/A:1008913828105","article-title":"Gastroesophageal\u00a0reflux disease, use of H2 receptor antagonists, and risk of esophageal and gastric cancer","volume":"11","author":"Farrow","year":"2000","journal-title":"Cancer Causes Control"},{"key":"10.1053\/j.gastro.2017.07.046_bib55","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/ijc.29688","article-title":"Age-specific risk factor\u00a0profiles of adenocarcinomas of the esophagus: a\u00a0pooled analysis from the international BEACON consortium","volume":"138","author":"Drahos","year":"2016","journal-title":"Int J Cancer"},{"key":"10.1053\/j.gastro.2017.07.046_bib56","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nrgastro.2014.69","article-title":"Progression of Barrett oesophagus: role of endoscopic and histological predictors","volume":"11","author":"Anaparthy","year":"2014","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2017.07.046_bib57","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1136\/gutjnl-2013-305372","article-title":"British Society of Gastroenterology guidelines on the diagnosis and management of Barrett\u2019s oesophagus","volume":"63","author":"Fitzgerald","year":"2014","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2017.07.046_bib58","doi-asserted-by":"crossref","first-page":"808","DOI":"10.7326\/0003-4819-157-11-201212040-00008","article-title":"Upper endoscopy for gastroesophageal reflux disease: best practice advice from the clinical guidelines committee of the American College of Physicians","volume":"157","author":"Shaheen","year":"2012","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.gastro.2017.07.046_bib59","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/nrgastro.2015.24","article-title":"Precision prevention of oesophageal adenocarcinoma","volume":"12","author":"Vaughan","year":"2015","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2017.07.046_bib60","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1136\/gutjnl-2012-304269","article-title":"Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review","volume":"63","author":"El-Serag","year":"2014","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2017.07.046_bib61","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.cgh.2006.09.016","article-title":"Time trends of gastroesophageal reflux disease: a systematic review","volume":"5","author":"El-Serag","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2017.07.046_bib62","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1136\/gutjnl-2011-300715","article-title":"Changes in\u00a0prevalence, incidence and spontaneous loss of gastro-oesophageal reflux symptoms: a prospective population-based cohort study, the HUNT study","volume":"61","author":"Ness-Jensen","year":"2012","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2017.07.046_bib63","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s10654-011-9596-z","article-title":"Increasing incidence of Barrett\u2019s oesophagus: a population-based study","volume":"26","author":"Coleman","year":"2011","journal-title":"Eur J Epidemiol"},{"key":"10.1053\/j.gastro.2017.07.046_bib64","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/00365520600815654","article-title":"Rising incidence\u00a0of clinically evident Barrett\u2019s oesophagus in The Netherlands: a nation-wide registry of pathology reports","volume":"42","author":"Post","year":"2007","journal-title":"Scand J Gastroenterol"},{"key":"10.1053\/j.gastro.2017.07.046_bib65","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1053\/j.gastro.2010.02.045","article-title":"Medications (NSAIDs, statins, proton pump inhibitors) and the risk of esophageal adenocarcinoma in patients with Barrett\u2019s esophagus","volume":"138","author":"Nguyen","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2017.07.046_bib66","doi-asserted-by":"crossref","first-page":"e006640","DOI":"10.1136\/bmjopen-2014-006640","article-title":"NSAIDs, statins, low-dose aspirin and PPIs, and the risk of oesophageal adenocarcinoma among patients with Barrett\u2019s oesophagus: a population-based case-control study","volume":"5","author":"Masclee","year":"2015","journal-title":"BMJ Open"},{"key":"10.1053\/j.gastro.2017.07.046_bib67","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/SLA.0000000000001438","article-title":"Antireflux surgery and risk of esophageal adenocarcinoma: a systematic review and meta-analysis","volume":"263","author":"Maret-Ouda","year":"2016","journal-title":"Ann Surg"},{"key":"10.1053\/j.gastro.2017.07.046_bib68","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1136\/gutjnl-2013-305997","article-title":"Acid-suppressive medications and risk of oesophageal adenocarcinoma in patients with Barrett\u2019s oesophagus: a systematic review and meta-analysis","volume":"63","author":"Singh","year":"2014","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2017.07.046_bib69","doi-asserted-by":"crossref","first-page":"e0169691","DOI":"10.1371\/journal.pone.0169691","article-title":"Proton pump inhibitors do not reduce the risk of esophageal adenocarcinoma in patients with Barrett\u2019s esophagus: a systematic review and meta-analysis","volume":"12","author":"Hu","year":"2017","journal-title":"PLoS One"},{"key":"10.1053\/j.gastro.2017.07.046_bib70","doi-asserted-by":"crossref","first-page":"883","DOI":"10.7326\/0003-4819-130-11-199906010-00003","article-title":"Association between body mass and adenocarcinoma of the esophagus and gastric cardia","volume":"130","author":"Lagergren","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.gastro.2017.07.046_bib71","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1093\/ije\/dys176","article-title":"Body mass index\u00a0in relation to oesophageal and oesophagogastric junction adenocarcinomas: a pooled analysis from the international BEACON consortium","volume":"41","author":"Hoyo","year":"2012","journal-title":"Int J Epidemiol"},{"key":"10.1053\/j.gastro.2017.07.046_bib72","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1093\/annonc\/mds244","article-title":"A\u00a0meta-analysis of body mass index and esophageal and gastric cardia adenocarcinoma","volume":"24","author":"Turati","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1053\/j.gastro.2017.07.046_bib73","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1038\/bjc.2017.29","article-title":"Body weight trajectories and risk of oesophageal and gastric cardia adenocarcinomas: a pooled analysis of NIH-AARP and PLCO Studies","volume":"116","author":"Petrick","year":"2017","journal-title":"Br J Cancer"},{"key":"10.1053\/j.gastro.2017.07.046_bib74","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1158\/1055-9965.EPI-11-0547","article-title":"The impact of obesity on the rise in esophageal adenocarcinoma incidence: estimates from a disease simulation model","volume":"20","author":"Kong","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1053\/j.gastro.2017.07.046_bib75","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1158\/1055-9965.EPI-10-0802","article-title":"Dating the rise of esophageal adenocarcinoma: analysis of Connecticut Tumor Registry data, 1940-2007","volume":"20","author":"Abrams","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1053\/j.gastro.2017.07.046_bib76","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1007\/s10620-016-4155-9","article-title":"Potential role of the microbiome in Barrett\u2019s esophagus and esophageal adenocarcinoma","volume":"61","author":"Snider","year":"2016","journal-title":"Dig Dis Sci"},{"key":"10.1053\/j.gastro.2017.07.046_bib77","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.gtc.2015.03.001","article-title":"Role of obesity in the pathogenesis and progression of Barrett\u2019s esophagus","volume":"44","author":"Chandar","year":"2015","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1053\/j.gastro.2017.07.046_bib78","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1001\/jama.290.1.66","article-title":"Obesity and estrogen as risk factors for gastroesophageal reflux symptoms","volume":"290","author":"Nilsson","year":"2003","journal-title":"JAMA"},{"key":"10.1053\/j.gastro.2017.07.046_bib79","doi-asserted-by":"crossref","first-page":"199","DOI":"10.7326\/0003-4819-143-3-200508020-00006","article-title":"Meta-analysis: obesity and the risk for gastroesophageal reflux disease\u00a0and its complications","volume":"143","author":"Hampel","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.gastro.2017.07.046_bib80","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.gtc.2013.11.009","article-title":"Obesity and GERD","volume":"43","author":"Chang","year":"2014","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1053\/j.gastro.2017.07.046_bib81","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/nrgastro.2011.73","article-title":"Influence of obesity on the risk of esophageal disorders","volume":"8","author":"Lagergren","year":"2011","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2017.07.046_bib82","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1111\/apt.13176","article-title":"Metabolic syndrome and the risk of Barrett\u2019s oesophagus in white males","volume":"41","author":"Thrift","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2017.07.046_bib83","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1016\/j.cgh.2015.06.041","article-title":"Association of serum levels of adipokines and insulin with risk of Barrett\u2019s esophagus: a systematic review and meta-analysis","volume":"13","author":"Chandar","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2017.07.046_bib84","doi-asserted-by":"crossref","first-page":"e4338","DOI":"10.1097\/MD.0000000000004338","article-title":"Metabolic syndrome is associated with increased risk of Barrett esophagus: a meta-analysis","volume":"95","author":"He","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1053\/j.gastro.2017.07.046_bib85","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1136\/gut.2007.131243","article-title":"Leptin and the risk of Barrett\u2019s oesophagus","volume":"57","author":"Kendall","year":"2008","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2017.07.046_bib86","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.cgh.2013.02.017","article-title":"Association between markers of obesity and progression from Barrett\u2019s esophagus to esophageal adenocarcinoma","volume":"11","author":"Duggan","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2017.07.046_bib87","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/1471-2407-14-103","article-title":"Metabolic risk factors for esophageal squamous cell carcinoma and adenocarcinoma: a prospective study of 580,000 subjects within the Me-Can project","volume":"14","author":"Lindkvist","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1053\/j.gastro.2017.07.046_bib88","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/cncr.30365","article-title":"Metabolic syndrome and risk of esophageal adenocarcinoma in elderly patients in the United States: an analysis of SEER-Medicare data","volume":"123","author":"Drahos","year":"2017","journal-title":"Cancer"},{"key":"10.1053\/j.gastro.2017.07.046_bib89","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1007\/s10552-015-0675-4","article-title":"Metabolic syndrome and esophageal and gastric cancer","volume":"26","author":"Lin","year":"2015","journal-title":"Cancer Causes Control"},{"key":"10.1053\/j.gastro.2017.07.046_bib90","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.canep.2016.02.008","article-title":"Metabolic syndrome in relation to Barrett\u2019s esophagus and esophageal adenocarcinoma: Results from a large population-based case-control study in the Clinical Practice Research Datalink","volume":"42","author":"Drahos","year":"2016","journal-title":"Cancer Epidemiol"},{"key":"10.1053\/j.gastro.2017.07.046_bib91","doi-asserted-by":"crossref","first-page":"e30181","DOI":"10.1371\/journal.pone.0030181","article-title":"Esophageal cancer metabolite biomarkers detected by LC-MS and NMR methods","volume":"7","author":"Zhang","year":"2012","journal-title":"PLoS One"},{"key":"10.1053\/j.gastro.2017.07.046_bib92","doi-asserted-by":"crossref","DOI":"10.1007\/s11306-016-1154-y","article-title":"Candidate serum\u00a0metabolite biomarkers for differentiating gastroesophageal reflux disease, Barrett\u2019s esophagus, and high-grade dysplasia\/esophageal adenocarcinoma","volume":"13","author":"Buas","year":"2017","journal-title":"Metabolomics"},{"key":"10.1053\/j.gastro.2017.07.046_bib93","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/ijc.29432","article-title":"General and abdominal obesity and risk of esophageal and gastric adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition","volume":"137","author":"Steffen","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1053\/j.gastro.2017.07.046_bib94","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/j.cgh.2013.05.009","article-title":"Central adiposity is associated with increased risk of esophageal inflammation, metaplasia, and adenocarcinoma: a systematic review and meta-analysis","volume":"11","author":"Singh","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2017.07.046_bib95","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/j.cgh.2016.05.032","article-title":"Inverse association between gluteofemoral obesity and risk of Barrett\u2019s esophagus in a pooled analysis","volume":"14","author":"Kendall","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2017.07.046_bib96","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/EDE.0b013e31828b0a26","article-title":"Abdominal fat and male excess of esophageal adenocarcinoma","volume":"24","author":"Lagergren","year":"2013","journal-title":"Epidemiology"},{"key":"10.1053\/j.gastro.2017.07.046_bib97","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.soard.2015.09.016","article-title":"Esophageal adenocarcinoma after obesity surgery in a population-based cohort study","volume":"13","author":"Maret-Ouda","year":"2017","journal-title":"Surg Obes Relat Dis"},{"key":"10.1053\/j.gastro.2017.07.046_bib98","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/dote.12194","article-title":"Association of Helicobacter pylori infection with esophageal adenocarcinoma and\u00a0squamous cell carcinoma: a meta-analysis","volume":"27","author":"Nie","year":"2014","journal-title":"Dis Esophagus"},{"key":"10.1053\/j.gastro.2017.07.046_bib99","doi-asserted-by":"crossref","first-page":"6098","DOI":"10.3748\/wjg.v19.i36.6098","article-title":"Helicobacter pylori infection and esophageal cancer risk: an updated meta-analysis","volume":"19","author":"Xie","year":"2013","journal-title":"World J Gastroenterol"},{"key":"10.1053\/j.gastro.2017.07.046_bib100","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1158\/1940-6207.CAPR-08-0109","article-title":"Helicobacter pylori and esophageal cancer risk: a meta-analysis","volume":"1","author":"Islami","year":"2008","journal-title":"Cancer Prev Res (Phila)"},{"key":"10.1053\/j.gastro.2017.07.046_bib101","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.cgh.2007.08.010","article-title":"Relationship between Helicobacter pylori infection and esophageal neoplasia: a meta-analysis","volume":"5","author":"Rokkas","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2017.07.046_bib102","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/infdis\/168.1.219","article-title":"The cohort effect and Helicobacter pylori","volume":"168","author":"Banatvala","year":"1993","journal-title":"J\u00a0Infect Dis"},{"key":"10.1053\/j.gastro.2017.07.046_bib103","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1017\/S0950268801005027","article-title":"Decreasing prevalence of helicobacter antibodies in Finland, with reference to the decreasing incidence of gastric cancer","volume":"126","author":"Rehnberg-Laiho","year":"2001","journal-title":"Epidemiol Infect"},{"key":"10.1053\/j.gastro.2017.07.046_bib104","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1172\/JCI38605","article-title":"Coadaptation of Helicobacter pylori and humans: ancient history, modern implications","volume":"119","author":"Atherton","year":"2009","journal-title":"J\u00a0Clin Invest"},{"key":"10.1053\/j.gastro.2017.07.046_bib105","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1136\/bmj.326.7392.737","article-title":"Prevalence of Helicobacter pylori in patients with gastro-oesophageal reflux disease: systematic review","volume":"326","author":"Raghunath","year":"2003","journal-title":"BMJ"},{"key":"10.1053\/j.gastro.2017.07.046_bib106","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/MAJ.0000000000000429","article-title":"The effect of Helicobacter pylori eradication therapy on the development of gastroesophageal reflux disease","volume":"349","author":"Tan","year":"2015","journal-title":"Am J Med Sci"},{"key":"10.1053\/j.gastro.2017.07.046_bib107","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/ajg.2009.734","article-title":"Is there an increased risk of GERD after Helicobacter pylori eradication?: a meta-analysis","volume":"105","author":"Yaghoobi","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2017.07.046_bib108","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djw132","article-title":"Eradication of Helicobacter pylori and gastric cancer: a systematic review and meta-analysis of cohort studies","volume":"108","author":"Doorakkers","year":"2016","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1053\/j.gastro.2017.07.046_bib109","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1111\/apt.12317","article-title":"Oesophageal bacterial biofilm changes in gastro-oesophageal reflux\u00a0disease, Barrett\u2019s and oesophageal carcinoma: association or causality?","volume":"37","author":"Blackett","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2017.07.046_bib110","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1093\/jnci\/91.2.156","article-title":"Human papillomavirus infection and esophageal cancer: a nationwide seroepidemiologic case-control study in Sweden","volume":"91","author":"Lagergren","year":"1999","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1053\/j.gastro.2017.07.046_bib111","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.canep.2016.01.014","article-title":"Human papillomavirus not detected in esophageal adenocarcinoma tumor specimens","volume":"41","author":"Antonsson","year":"2016","journal-title":"Cancer Epidemiol"},{"key":"10.1053\/j.gastro.2017.07.046_bib112","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jcv.2010.11.015","article-title":"Human papillomavirus is detectable in Barrett\u2019s esophagus and\u00a0esophageal carcinoma but is unlikely to be of any etiologic significance","volume":"50","author":"Iyer","year":"2011","journal-title":"J\u00a0Clin Virol"},{"key":"10.1053\/j.gastro.2017.07.046_bib113","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1053\/j.seminoncol.2015.09.005","article-title":"Microbiome and potential targets for chemoprevention of esophageal adenocarcinoma","volume":"43","author":"Neto","year":"2016","journal-title":"Semin Oncol"},{"key":"10.1053\/j.gastro.2017.07.046_bib114","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3389\/fmicb.2016.00459","article-title":"Characterization of the gut microbiome using 16S or shotgun metagenomics","volume":"7","author":"Jovel","year":"2016","journal-title":"Front Microbiol"},{"key":"10.1053\/j.gastro.2017.07.046_bib115","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1093\/jnci\/djq289","article-title":"Cigarette smoking and adenocarcinomas of the esophagus and esophagogastric junction: a pooled analysis from the international BEACON consortium","volume":"102","author":"Cook","year":"2010","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1053\/j.gastro.2017.07.046_bib116","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1053\/j.gastro.2011.10.034","article-title":"Tobacco smoking increases the risk of high-grade dysplasia and cancer among patients with Barrett\u2019s esophagus","volume":"142","author":"Coleman","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2017.07.046_bib117","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/ajg.2012.387","article-title":"Risk factors in the development of esophageal adenocarcinoma","volume":"108","author":"Pohl","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2017.07.046_bib118","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1177\/2050640614523596","article-title":"Risk factors for the development of oesophageal adenocarcinoma in Barrett\u2019s oesophagus: a UK primary care retrospective nested case-control study","volume":"2","author":"Cooper","year":"2014","journal-title":"United Eur Gastroenterol J"},{"key":"10.1053\/j.gastro.2017.07.046_bib119","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1158\/1055-9965.EPI-04-0509","article-title":"Risk factors, DNA damage, and disease progression in Barrett\u2019s esophagus","volume":"14","author":"Olliver","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1053\/j.gastro.2017.07.046_bib120","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s13148-016-0273-7","article-title":"Global DNA methylation patterns in Barrett\u2019s esophagus, dysplastic Barrett\u2019s, and esophageal adenocarcinoma are associated with BMI, gender, and tobacco use","volume":"8","author":"Kaz","year":"2016","journal-title":"Clin Epigenetics"},{"key":"10.1053\/j.gastro.2017.07.046_bib121","article-title":"Smoking cessation and risk of esophageal cancer by histological type: systematic review and meta-analysis","volume":"109","author":"Xie","year":"2017","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1053\/j.gastro.2017.07.046_bib122","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1007\/BF02071391","article-title":"Effects of transdermal nicotine on lower esophageal sphincter and esophageal motility","volume":"41","author":"Kadakia","year":"1996","journal-title":"Dig Dis Sci"},{"key":"10.1053\/j.gastro.2017.07.046_bib123","first-page":"203","article-title":"The fractions of cancer attributable to modifiable factors: a global review","volume":"44","author":"Whiteman","year":"2016","journal-title":"Cancer\u00a0Epidemiol"},{"key":"10.1053\/j.gastro.2017.07.046_bib124","doi-asserted-by":"crossref","first-page":"d1584","DOI":"10.1136\/bmj.d1584","article-title":"Alcohol attributable burden of incidence of cancer in eight European countries based on results from prospective cohort study","volume":"342","author":"Sch\u00fctze","year":"2011","journal-title":"BMJ"},{"key":"10.1053\/j.gastro.2017.07.046_bib125","unstructured":"World Cancer Research Fund International\/American Institute for Cancer Research. Continuous Update Project Report: Diet, Nutrition, Physical Activity and Oesophageal Cancer.\u00a02016."},{"key":"10.1053\/j.gastro.2017.07.046_bib126","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1136\/gut.2010.233866","article-title":"Alcohol intake and risk of oesophageal adenocarcinoma: a pooled analysis from the BEACON Consortium","volume":"60","author":"Freedman","year":"2011","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2017.07.046_bib127","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1038\/ajg.2014.206","article-title":"Alcohol and the risk of Barrett\u2019s esophagus: a pooled analysis from the\u00a0International BEACON Consortium","volume":"109","author":"Thrift","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2017.07.046_bib128","doi-asserted-by":"crossref","first-page":"e52192","DOI":"10.1371\/journal.pone.0052192","article-title":"The role of tobacco, alcohol, and obesity in neoplastic progression to esophageal adenocarcinoma: a prospective study of Barrett\u2019s esophagus","volume":"8","author":"Hardikar","year":"2013","journal-title":"PLoS One"},{"key":"10.1053\/j.gastro.2017.07.046_bib129","doi-asserted-by":"crossref","first-page":"e105612","DOI":"10.1371\/journal.pone.0105612","article-title":"Alcohol consumption and the neoplastic progression in Barrett\u2019s esophagus: a systematic review and meta-analysis","volume":"9","author":"Lou","year":"2014","journal-title":"PLoS One"},{"key":"10.1053\/j.gastro.2017.07.046_bib130","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/CEJ.0000000000000227","article-title":"Associations of alcohol use disorders with esophageal and gastric cancers: a population-based study in Sweden","volume":"26","author":"Ji","year":"2017","journal-title":"Eur J Cancer Prev"},{"key":"10.1053\/j.gastro.2017.07.046_bib131","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.canep.2012.03.001","article-title":"The importance of exposure rate on odds ratios by cigarette smoking and alcohol consumption for esophageal adenocarcinoma and squamous cell carcinoma in the Barrett\u2019s Esophagus and Esophageal Adenocarcinoma Consortium","volume":"36","author":"Lubin","year":"2012","journal-title":"Cancer Epidemiol"},{"key":"10.1053\/j.gastro.2017.07.046_bib132","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/nure.12032","article-title":"Dietary fiber and the risk of precancerous lesions and cancer of the esophagus: a systematic review and meta-analysis","volume":"71","author":"Coleman","year":"2013","journal-title":"Nutr Rev"},{"key":"10.1053\/j.gastro.2017.07.046_bib133","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1017\/S0007114515004444","article-title":"Dietary magnesium, calcium:magnesium ratio and risk of reflux oesophagitis, Barrett\u2019s oesophagus and oesophageal adenocarcinoma: a population-based case-control study","volume":"115","author":"Dai","year":"2016","journal-title":"Br J Nutr"},{"key":"10.1053\/j.gastro.2017.07.046_bib134","first-page":"1966","article-title":"Intakes of dietary folate and other B vitamins are associated with risks of esophageal adenocarcinoma, Barrett\u2019s esophagus, and reflux esophagitis","volume":"143","author":"Sharp","year":"2013","journal-title":"J\u00a0Nutr"},{"key":"10.1053\/j.gastro.2017.07.046_bib135","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1017\/S0007114511000742","article-title":"Vitamin D, calcium and dairy intake, and risk of oesophageal adenocarcinoma and its precursor conditions","volume":"106","author":"Mulholland","year":"2011","journal-title":"Br J Nutr"},{"key":"10.1053\/j.gastro.2017.07.046_bib136","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s10552-008-9242-6","article-title":"Glycemic index, carbohydrate and fiber intakes and risk of reflux esophagitis, Barrett\u2019s esophagus, and esophageal adenocarcinoma","volume":"20","author":"Mulholland","year":"2009","journal-title":"Cancer Causes Control"},{"key":"10.1053\/j.gastro.2017.07.046_bib137","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1002\/ijc.26108","article-title":"Dietary fat and meat intakes and risk of reflux esophagitis, Barrett\u2019s esophagus and esophageal adenocarcinoma","volume":"129","author":"O\u2019Doherty","year":"2011","journal-title":"Int J cancer"},{"key":"10.1053\/j.gastro.2017.07.046_bib138","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1007\/s10552-010-9652-0","article-title":"Iron intake and markers of iron status and risk of Barrett\u2019s esophagus and esophageal adenocarcinoma","volume":"21","author":"O\u2019Doherty","year":"2010","journal-title":"Cancer Causes Control"},{"key":"10.1053\/j.gastro.2017.07.046_bib139","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1002\/ijc.27434","article-title":"Toenail trace element status and risk of Barrett\u2019s oesophagus and oesophageal adenocarcinoma: results from the FINBAR study","volume":"131","author":"O\u2019Rorke","year":"2012","journal-title":"Int J cancer"},{"key":"10.1053\/j.gastro.2017.07.046_bib140","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.3748\/wjg.v13.i10.1585","article-title":"Risk factors for Barrett\u2019s oesophagus and oesophageal adenocarcinoma: results from the FINBAR study","volume":"13","author":"Anderson","year":"2007","journal-title":"World J Gastroenterol"},{"key":"10.1053\/j.gastro.2017.07.046_bib141","first-page":"1757","article-title":"Dietary antioxidant and mineral intake in humans is associated with reduced risk of esophageal adenocarcinoma but not reflux esophagitis or Barrett\u2019s esophagus","volume":"140","author":"Murphy","year":"2010","journal-title":"J\u00a0Nutr"},{"key":"10.1053\/j.gastro.2017.07.046_bib142","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/1471-230X-14-101","article-title":"Physical activity is associated with reduced risk of esophageal cancer, particularly esophageal adenocarcinoma: a systematic review and meta-analysis","volume":"14","author":"Singh","year":"2014","journal-title":"BMC Gastroenterol"},{"key":"10.1053\/j.gastro.2017.07.046_bib143","doi-asserted-by":"crossref","first-page":"e88082","DOI":"10.1371\/journal.pone.0088082","article-title":"Physical activity and risks of esophageal and gastric cancers: a meta-analysis","volume":"9","author":"Chen","year":"2014","journal-title":"PLoS One"},{"key":"10.1053\/j.gastro.2017.07.046_bib144","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s10552-009-9493-x","article-title":"Prospective study of physical activity and risk of primary adenocarcinomas of the oesophagus and stomach in the EPIC (European Prospective Investigation into Cancer and nutrition) cohort","volume":"21","author":"Huerta","year":"2010","journal-title":"Cancer Causes Control"},{"key":"10.1053\/j.gastro.2017.07.046_bib145","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.amepre.2008.09.033","article-title":"Physical activity and esophageal and gastric carcinoma in a large prospective study","volume":"36","author":"Leitzmann","year":"2009","journal-title":"Am J Prev Med"},{"key":"10.1053\/j.gastro.2017.07.046_bib146","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1001\/jamainternmed.2016.1548","article-title":"Association of leisure-time physical activity with risk of 26 types of cancer in 1.44 million adults","volume":"176","author":"Moore","year":"2016","journal-title":"JAMA Intern Med"},{"key":"10.1053\/j.gastro.2017.07.046_bib147","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1158\/1055-9965.EPI-15-0237","article-title":"Leisure-time spent sitting and site-specific cancer incidence in a large U.S. cohort","volume":"24","author":"Patel","year":"2015","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1053\/j.gastro.2017.07.046_bib148","volume":"106","author":"Schmid","year":"2014","journal-title":"Television viewing and time spent sedentary in relation to cancer risk: a meta-analysis. J Natl Cancer Inst"},{"key":"10.1053\/j.gastro.2017.07.046_bib149","doi-asserted-by":"crossref","first-page":"e84805","DOI":"10.1371\/journal.pone.0084805","article-title":"Physical activity and sedentary behavior in relation to esophageal and gastric cancers in the NIH-AARP cohort","volume":"8","author":"Cook","year":"2013","journal-title":"PLoS One"},{"key":"10.1053\/j.gastro.2017.07.046_bib150","doi-asserted-by":"crossref","first-page":"e0117922","DOI":"10.1371\/journal.pone.0117922","article-title":"The feasibility of an exercise intervention in males at risk of oesophageal adenocarcinoma: a randomized controlled trial","volume":"10","author":"Winzer","year":"2015","journal-title":"PLoS One"},{"key":"10.1053\/j.gastro.2017.07.046_bib151","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1002\/ijc.28869","article-title":"Hormone replacement therapy and oral contraceptives and risk of oesophageal adenocarcinoma: a systematic review and meta-analysis","volume":"135","author":"Lagergren","year":"2014","journal-title":"Int J Cancer"},{"key":"10.1053\/j.gastro.2017.07.046_bib152","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1002\/ijc.30588","article-title":"Menopausal hormone therapy and the risk of esophageal and gastric cancer","volume":"140","author":"Brusselaers","year":"2017","journal-title":"Int J Cancer"},{"key":"10.1053\/j.gastro.2017.07.046_bib153","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1016\/j.ejca.2010.03.032","article-title":"Reproductive and sex hormonal factors and oesophageal and gastric junction adenocarcinoma: a pooled analysis","volume":"46","author":"Cronin-Fenton","year":"2010","journal-title":"Eur J Cancer"},{"key":"10.1053\/j.gastro.2017.07.046_bib154","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2011.11.019","article-title":"Nonsteroidal anti-inflammatory drug use reduces risk of adenocarcinomas of the esophagus and esophagogastric junction in a pooled analysis","volume":"142","author":"Liao","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2017.07.046_bib155","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(10)62110-1","article-title":"Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials","volume":"377","author":"Rothwell","year":"2011","journal-title":"Lancet"},{"key":"10.1053\/j.gastro.2017.07.046_bib156","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.cgh.2012.12.036","article-title":"Statins are associated with reduced risk of esophageal cancer, particularly in patients with Barrett\u2019s esophagus: a systematic review and meta-analysis","volume":"11","author":"Singh","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2017.07.046_bib157","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1159\/000097947","article-title":"Non-steroidal anti-inflammatory drugs, lower oesophageal sphincter-relaxing drugs and oesophageal cancer. A case-control study","volume":"74","author":"Ranka","year":"2006","journal-title":"Digestion"},{"key":"10.1053\/j.gastro.2017.07.046_bib158","doi-asserted-by":"crossref","first-page":"165","DOI":"10.7326\/0003-4819-133-3-200008010-00007","article-title":"Association between medications that relax the lower esophageal sphincter and risk for esophageal adenocarcinoma","volume":"133","author":"Lagergren","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.gastro.2017.07.046_bib159","first-page":"749","article-title":"Risk of esophageal and gastric adenocarcinomas in relation to use of calcium channel blockers, asthma drugs, and other medications that promote gastroesophageal reflux","volume":"7","author":"Vaughan","year":"1998","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1053\/j.gastro.2017.07.046_bib160","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1517\/14740338.7.2.173","article-title":"The effect of anticholinergic agents on gastro-oesophageal reflux and related disorders","volume":"7","author":"van Soest","year":"2008","journal-title":"Expert Opin Drug Saf"},{"key":"10.1053\/j.gastro.2017.07.046_bib161","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1007\/s10637-013-9984-1","article-title":"Cardiac glycosides in cancer therapy: from preclinical investigations towards clinical trials","volume":"31","author":"Slingerland","year":"2013","journal-title":"Invest New Drugs"},{"key":"10.1053\/j.gastro.2017.07.046_bib162","doi-asserted-by":"crossref","first-page":"988","DOI":"10.2174\/1389450115666140908125025","article-title":"Na+\/K+ ATPase inhibitors in cancer","volume":"15","author":"Alevizopoulos","year":"2014","journal-title":"Curr Drug Targets"},{"key":"10.1053\/j.gastro.2017.07.046_bib163","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1016\/S0140-6736(17)31462-9","article-title":"Oesophageal cancer","volume":"390","author":"Lagergren","year":"2017","journal-title":"Lancet"},{"key":"10.1053\/j.gastro.2017.07.046_bib164","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1001\/jamaoncol.2015.0735","article-title":"The Global burden of cancer 2013","volume":"1","author":"Fitzmaurice","year":"2015","journal-title":"JAMA Oncol"},{"key":"10.1053\/j.gastro.2017.07.046_bib165","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1002\/ijc.29227","article-title":"Cancer survival in China, 2003-2005: a population-based study","volume":"136","author":"Zeng","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1053\/j.gastro.2017.07.046_bib166","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.surg.2012.03.025","article-title":"Population-based esophageal cancer survival after resection without neoadjuvant therapy: an update","volume":"152","author":"Ruteg\u00e5rd","year":"2012","journal-title":"Surgery"},{"key":"10.1053\/j.gastro.2017.07.046_bib167","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jtcvs.2012.12.058","article-title":"Effect of Barrett\u2019s esophagus surveillance on esophageal preservation, tumor stage, and survival with esophageal adenocarcinoma","volume":"146","author":"Grant","year":"2013","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1053\/j.gastro.2017.07.046_bib168","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/JTO.0b013e3182397751","article-title":"Temporal trends in\u00a0long-term survival and cure rates in esophageal cancer: a SEER database analysis","volume":"7","author":"Dubecz","year":"2012","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1053\/j.gastro.2017.07.046_bib169","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001556.pub3","article-title":"Preoperative chemotherapy for resectable thoracic esophageal cancer","author":"Kidane","year":"2015","journal-title":"Cochrane database Syst Rev"},{"key":"10.1053\/j.gastro.2017.07.046_bib170","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1200\/JCO.2014.55.9070","article-title":"Tumor stage after neoadjuvant chemotherapy determines survival after surgery for adenocarcinoma of the esophagus and\u00a0esophagogastric junction","volume":"32","author":"Davies","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1053\/j.gastro.2017.07.046_bib171","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1200\/JCO.2004.08.154","article-title":"Multivariate prognostic factor analysis in locally advanced and metastatic esophago-gastric cancer\u2013pooled analysis from three multicenter, randomized, controlled trials using individual patient data","volume":"22","author":"Chau","year":"2004","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1053\/j.gastro.2017.07.046_bib172","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1097\/SLA.0000000000001101","article-title":"Mass spectrometric analysis of exhaled breath for the identification of volatile organic compound biomarkers in esophageal and gastric adenocarcinoma","volume":"262","author":"Kumar","year":"2015","journal-title":"Ann Surg"},{"key":"10.1053\/j.gastro.2017.07.046_bib173","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1053\/j.gastro.2012.09.060","article-title":"Health benefits and cost effectiveness of endoscopic and nonendoscopic cytosponge screening for Barrett\u2019s esophagus","volume":"144","author":"Benaglia","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2017.07.046_bib174","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2017.07.041","article-title":"Clinical endoscopic management for esophageal adenocarcinoma and squamous cell carcinoma early lesions","author":"di Pietro","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2017.07.046_bib175","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/ng.3659","article-title":"Mutational signatures in\u00a0esophageal adenocarcinoma define etiologically distinct subgroups with therapeutic relevance","volume":"48","author":"Secrier","year":"2016","journal-title":"Nat Genet"},{"key":"10.1053\/j.gastro.2017.07.046_bib176","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1097\/EDE.0000000000000471","article-title":"The role of\u00a0molecular pathological epidemiology in the study of neoplastic and non-neoplastic diseases in the era of precision medicine","volume":"27","author":"Ogino","year":"2016","journal-title":"Epidemiology"},{"key":"10.1053\/j.gastro.2017.07.046_bib177","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s00535-016-1272-3","article-title":"Molecular pathological epidemiology: new developing frontiers of big data science to study etiologies and pathogenesis","volume":"52","author":"Hamada","year":"2017","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1053\/j.gastro.2017.07.046_bib178","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s10552-016-0845-z","article-title":"Proceedings of the third international molecular pathological epidemiology (MPE) meeting","volume":"28","author":"Campbell","year":"2017","journal-title":"Cancer Causes Control"}],"container-title":["Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508517359784?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508517359784?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T00:30:53Z","timestamp":1602635453000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0016508517359784"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":178,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S0016508517359784"],"URL":"https:\/\/doi.org\/10.1053\/j.gastro.2017.07.046","relation":{},"ISSN":["0016-5085"],"issn-type":[{"value":"0016-5085","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Epidemiology of Esophageal Adenocarcinoma","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.gastro.2017.07.046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by the AGA Institute","name":"copyright","label":"Copyright"}]}}